Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (291-300 of 536) with videos related to

Pageof 54
Sort By:
Bone Marrow Transplantation|November 21, 2021
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimensJanny M Yao, Dongyun Yang, Mary C Clark, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Longitudinal single cell RNA-sequencing reveals evolution of micro- and macro-states in chronic myeloid leukemiaDavid E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
American Journal of Hematology|May 27, 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Shanpeng Li, Jianying Zhang, et al.
Blood Cancer Journal|July 3, 2021
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomesIbrahim Aldoss, Raju Pillai, Dongyun Yang, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemiaWilliam Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Haematologica|June 12, 2013
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germlineJason H Mendler, Kati Maharry, Heiko Becker, et al.
Blood Advances|September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label studyHaris Ali, Ni-Chun Tsai, Timothy Synold, et al.
American Journal of Hematology|March 15, 2021
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351)Amandeep Salhotra, Ahmed Aribi, Dat Ngo, et al.
Blood|June 5, 2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E Kolitz, Stephen L George, Guido Marcucci, et al.
Pageof 54

Showing results (291-300 of 536) with videos related to

Sort By:
Pageof 54
Bone Marrow Transplantation|November 21, 2021
Tacrolimus initial steady state level in post-transplant cyclophosphamide-based GvHD prophylaxis regimensJanny M Yao, Dongyun Yang, Mary C Clark, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Longitudinal single cell RNA-sequencing reveals evolution of micro- and macro-states in chronic myeloid leukemiaDavid E Frankhouser, Dandan Zhao, Yu-Hsuan Fu, et al.
American Journal of Hematology|May 27, 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemiaTamer Othman, Shanpeng Li, Jianying Zhang, et al.
Blood Cancer Journal|July 3, 2021
Late and very late relapsed acute lymphoblastic leukemia: clinical and molecular features, and treatment outcomesIbrahim Aldoss, Raju Pillai, Dongyun Yang, et al.
The Journal of Clinical Investigation|March 3, 2011
NKp46 identifies an NKT cell subset susceptible to leukemic transformation in mouse and humanJianhua Yu, Takeki Mitsui, Min Wei, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 8, 2007
Phase I study of decitabine alone or in combination with valproic acid in acute myeloid leukemiaWilliam Blum, Rebecca B Klisovic, Bjoern Hackanson, et al.
Haematologica|June 12, 2013
In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germlineJason H Mendler, Kati Maharry, Heiko Becker, et al.
Blood Advances|September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label studyHaris Ali, Ni-Chun Tsai, Timothy Synold, et al.
American Journal of Hematology|March 15, 2021
Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA-Ven) or liposomal daunorubicin-cytarabine (CPX-351)Amandeep Salhotra, Ahmed Aribi, Dat Ngo, et al.
Blood|June 5, 2010
P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808Jonathan E Kolitz, Stephen L George, Guido Marcucci, et al.
Pageof 54